Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “TEVA PHARMACEUTICAL INDUSTRIES, LTD.”

302 pharma patents match "TEVA PHARMACEUTICAL INDUSTRIES, LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 302
Index total 30,257
Page 7 / 13

Quick answer

This filtered view shows 302 pharmaceutical patents matching "TEVA PHARMACEUTICAL INDUSTRIES, LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

302 results for “TEVA PHARMACEUTICAL INDUSTRIES, LTD.” · 30,257 patents in full index Clear search

  1. US 7674935

    Crystal forms of O-desmethylvenlafaxine

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 9, 2010 · Expires Mar 4, 2030

    granted
  2. US 7674923

    Process for preparing forms of atorvastatin calcium substantially free of impurities

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 9, 2010 · Expires Mar 4, 2030

    granted
  3. US 7671071

    Polymorphic Form XVI of fexofenadine hydrochloride

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 2, 2010 · Expires Feb 25, 2030

    granted
  4. US 7632841

    2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 15, 2009 · Expires Dec 10, 2029

    granted
  5. US 7629458

    Preparation of levofloxacin and hemihydrate thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 8, 2009 · Expires Dec 3, 2029

    granted
  6. US 7622588

    Method for the purification of lansoprazole

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted
  7. US 7618976

    Methods for the production of sildenafil base and citrate salt

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 17, 2009 · Expires Nov 12, 2029

    granted
  8. US 7619112

    Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 17, 2009 · Expires Nov 12, 2029

    granted
  9. US 7619117

    Rasagiline formulations and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 17, 2009 · Expires Nov 12, 2029

    granted
  10. US 7611722

    Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  11. US 7612203

    Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  12. US 7605274

    Carvedilol

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted
  13. US 7605290

    Processes for the synthesis of O-desmethylvenlafaxine

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted
  14. US 7598420

    Rasagiline formulations and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted
  15. US 7598396

    Crystalline solids of carvedilol and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted
  16. US 7582759

    Diastereomeric purification of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Sep 1, 2009 · Expires Aug 27, 2029

    granted
  17. US 7579333

    Therapy using a combination of raloxifene and alendronate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 25, 2009 · Expires Aug 20, 2029

    granted
  18. US 7572641

    Pharmaceutical compositions comprising meloxicam and methods of their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 11, 2009 · Expires Aug 6, 2029

    granted
  19. US 7572834

    Rasagiline formulations and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 11, 2009 · Expires Aug 6, 2029

    granted
  20. US 7563930

    Crystal forms of Cinacalcet HCI and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 21, 2009 · Expires Jul 16, 2029

    granted
  21. US 7563918

    Solid and crystalline ibandronate sodium and processes for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 21, 2009 · Expires Jul 16, 2029

    granted
  22. US 7547787

    Processes for preparing montelukast sodium

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted
  23. US 7547806

    Tannate salt of rasagiline

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted
  24. US 7538136

    Crystalline forms of atorvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 26, 2009 · Expires May 21, 2029

    granted